HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Viki Bockstal Selected Research

Ebola Vaccines

1/2022Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
1/2022Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study.
1/2021Durable natural killer cell responses after heterologous two-dose Ebola vaccination.
1/2019Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Viki Bockstal Research Topics

Disease

7Vaccinia
01/2022 - 01/2020
6Ebola Hemorrhagic Fever
01/2022 - 01/2019
5Infections
01/2020 - 01/2011
4Malaria
01/2022 - 01/2011
4Pain (Aches)
01/2022 - 01/2019
4Headache (Headaches)
01/2022 - 01/2019
2Parasitemia
01/2020 - 01/2016
2Inflammation (Inflammations)
01/2020 - 03/2010
2Anemia
01/2016 - 03/2010
1Fever (Fevers)
01/2022
1Virus Diseases (Viral Diseases)
01/2021
1Fatigue
01/2021
1Myalgia
01/2021
1Cytokine Release Syndrome
01/2020
1Poliomyelitis (Polio)
11/2018
1Chronic Disease (Chronic Diseases)
03/2010
1Trypanosomiasis
03/2010

Drug/Important Bio-Agent (IBA)

8VaccinesIBA
01/2022 - 01/2019
7smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA
01/2022 - 01/2019
6Glycoproteins (Glycoprotein)IBA
01/2022 - 01/2020
4Ebola VaccinesIBA
01/2022 - 01/2019
3NucleoproteinsIBA
01/2022 - 01/2021
3AntibodiesIBA
01/2021 - 01/2011
2CytokinesIBA
01/2020 - 01/2020
2Interleukin-10 (Interleukin 10)IBA
01/2020 - 03/2010
2Proteins (Proteins, Gene)FDA Link
03/2016 - 01/2016
1AntigensIBA
01/2020
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2020
1Interleukin-27 (Interleukin 27)IBA
01/2020
1SolutionsIBA
11/2018
1Viral RNAIBA
03/2016
1Differentiation AntigensIBA
01/2016
1Immunoglobulin G (IgG)IBA
01/2016
1Peptides (Polypeptides)IBA
01/2016
1PerforinIBA
01/2016
1ProstaglandinsIBA
06/2011
1Chemokine CXCL12IBA
01/2011
1Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
03/2010
1GlycolipidsIBA
03/2010
1IronIBA
03/2010

Therapy/Procedure

1Injections
01/2021
1Therapeutics
01/2019